Mirae Asset Securities & Investments (USA)

Mirae Asset Capital Life Science is a Boston-based venture capital firm formed in 2023 as a joint venture between Mirae Asset Capital and Mirae Asset Global Investments. It backs U.S. life sciences companies, with emphasis on biotechnology, pharmaceuticals, oncology and HealthTech businesses developing safe, effective treatments. The firm applies a strategy rooted in drug development, clinical data and market dynamics, invests at later-stage venture rounds and has acted as a lead investor in Series C financing.